Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 3: Predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody profile

Helicobacter

Volumn 10, Issue 4, 2005, Pages 288-297

  Weller, Clive ^a   Charlett, André ^c   Oxlade, Norman L ^a,d   Dobbs, Sylvia M ^a,b   Dobbs, R John ^a,b   Peterson, Dale W ^d   Bjarnason, Ingvar T ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Biological gradients; Biomarker; Helicobacter pylori; Idiopathic parkinsonism; Objective measures facets; Serum antibody immunoblot profile

Indexed keywords

ANTIPARKINSON AGENT; BACTERIAL ANTIGEN; CAGA PROTEIN; DECARBOXYLASE INHIBITOR; IMMUNOGLOBULIN G ANTIBODY; LEVODOPA; MUSCARINIC RECEPTOR BLOCKING AGENT; SELEGILINE; UREASE; VACUOLATING TOXIN;

ADULT; AGED; ANTHROPOMETRY; ANTIBODY BLOOD LEVEL; ARTICLE; BODY POSTURE; CONTROLLED STUDY; DIGESTIVE SYSTEM INFLAMMATION; DISEASE SEVERITY; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL INFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC DISEASE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; NONHUMAN; PARKINSONISM; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PSYCHOMOTOR DISORDER; REACTION TIME; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CHRONIC DISEASE; FEMALE; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

HELICOBACTER; HELICOBACTER PYLORI; PARKINSONIA;

EID: 23344433801     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2005.00329.x     Document Type: Article

References (42)

1. Dobbs RJ, Dobbs SM, Weller C, et al. Role of chronic infection and inflammation in the gastrointestinal tract in the aetiology and pathogenesis of idiopathic parkinsonism. Part 1: Eradication of Helicobacter in the cachexia of idiopathic parkinsonism. Helicobacter 2005;10:267-75.
2. Bjarnason IT, Charlett A, Dobbs RJ, et al. Role of chronic infection and inflammation in the gastrointestinal tract in the aetiology and pathogenesis of idopathic parkinsonism. Part 2: Response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomised, double-blind, placebo-controlled efficacy study. Helicobacter 2005;10:276-87.
3. Charlett A, Dobbs RJ, Purkiss AG, et al. Cortisol is higher in parkinsonism and associated with gait deficit. Acta Neurol Scand 1998;97:77-85.
4. Charlett A, Purkiss AG, Dobbs SM, Weller C, Peterson DW. Association of circulating TNF-α and IL-6 with ageing and parkinsonism. Acta Neurol Scand 1999;100:34-41.
5. Strang RR. The association of gastro-duodenal ulceration with Parkinson's disease. Med J Austr 1965;52:842-3.
6. Dobbs RJ, Charlett A, Dobbs SM, Weller C, Peterson DW. Parkinsonism: differential age-trend in Helicobacter pylori antibody. Alim Pharm Ther 2000;14:1199-205.
7. Charlett A, Dobbs SM, Dobbs RJ, Peterson DW, Weller C. Could antibodies to Helicobacter pylori urease explain the facets of parkinsonism quantified in subjects who have and have not passed the diagnostic threshold? Br J Clin Pharmac 1999;48:888P.
8. Mathialogan R, Loizoa S, Beales ILP, et al. Who gets false-negative H. pylori (HP) ELISA results? Gut 1994;35 (Suppl. 5):S51.
9. 13C-urea breath test, and serology. Scand J Gastroenterol 2000;35:138-41.
10. Kokkola A, Sipponen P, Rautelin H, et al. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Alim Pharm Ther 2002;16:515-20.
11. Baig SM, Qureshi GA, Minami M. The interrelation between the deficiency of vitamin B12 and neurotoxicity of homocysteaine with nitrite in some neurologic disorders. Biogenic Amines 1998;14:1-14.
12. Hill AB. The environment and disease: association or causation? Proc Roy Soc Med 1965;58:295-300.
13. Bowes SG, Dobbs RJ, Henley M, et al. Objective evidence for tolerance, against a background of improvement, during maintenance therapy with controlled release levodopa/carbidopa. Eur J Clin Pharmacol 1992;43:483-9.
14. Kirollos C, O'Neill CJA, Dobbs RJ, et al. Quantification of the cardinal signs of parkinsonism and of associated disability in spouses of sufferers. Age Ageing 1993;22:20-6.
15. Dobbs RJ, Bowes SG, Charlett A, et al. Hypothesis: the bradyphrenia of parkinsonism is a nosological entity. Acta Neurol Scand 1993;87:255-61.
16. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Nenrol 1992;32 (Suppl.):S125-7.
17. Calne DB. Parkinson's disease is not one disease. Parkinsonism Relat Disord 2001;7:3-7.
18. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. In: Pichot T, ed. Psychological Measurements in Psychopharmacology, 7, Modern Problems in Psychiatry. Basel: Karger, 1974;151-9.
19. Kirollos C, Charlett A, Bowes SG, et al. Time course of physical and psychological responses to selegiline monotherapy in newly diagnosed, idiopathic parkinsonism. Eur J Clin Pharmacol 1996;50:7-18.
20. Charlett A, Weller C, Dobbs SM, Dobbs RJ. Breadth of base whilst walking: effect of ageing and parkinsonism. Age Ageing 1998;27:49-54.
21. Bowes SG, Clark PK, Charlett A, et al. Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: reliability, sensitivity and specificity of measures of brady- or hypokinesia. Br J Clin Pharmac 1991;31:295-304.
22. Bowes SG, Clark PK, Leeman AL, et al. Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy. Br J Clin Pharmac 1990;30:13-24.
23. Webster DD. Clinical analysis of the disability of Parkinson's disease. Mod Treat 1968;5:257-82.
24. Stata Base Reference Manual (vol. 3 N-R, release 8). College Station, Texas: Stata Press, Stata Corporation, 2003.
25. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
26. Murray LJ, McCrum EE, Evans AE, Bamford KB. Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland. Int J Epidemiol 1997;26:880-7.
27. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6.
28. Kwon HJ, Kang JO, Cho SH, et al. Presence of human Mycoplasma DNA in gastric tissue samples from Korean chronic gastritis patients. Cancer Sci 2004;95:311-5.
29. Bowes SG, Charlett A, Dobbs RJ, et al. Gait in relation to ageing and idiopathic Parkinsonism. Scan J Rehab Med 1992;24:181-6.
30. Mermin J, Lule J, Ekwaru JP, et al. Effect of cotimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004;364:1428-34.
31. Kountouras J, Deretzi G, Zavos C, et al. Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2005;12:139-43.
32. Xing L, Washington J, Seaton J, Kauffman G. Monoamine oxidase B inhibition reduces gastric mucosal blood flow, basal acid secretion, and cold water restraint-induced gastric mucosal injury in rats. Dig Dis Sci 1990;35:61-5.
33. Glavin GB. Dopamine and gastroprotection. The brain-gut axis. Dig Dis Sci 1991;36:1670-2.
34. Baak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Baak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
35. Lang AE, Lozano AM. Parkinson's disease. New Eng J Med 1998;339:1044-53.
36. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-7.
37. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 1976;2:1525-36.
38. Critchley M. The neurology of old age. Lancet 1931;i:1221-30.
39. Barbeau A. Aging and the extrapyramidal system. J Am Geriatr Soc 1973;21:145-9.
40. Dobbs RJ, Lubel DD, Charlett A, et al. Hypothesis: age-associated changes in gait represent, in part, a tendency towards parkinsonism. Age Ageing 1992;21:221-5.
41. Prettyman R. Extrapyramidal signs in cognitively intact elderly people. Age Ageing 1998;27:557-60.
42. Fox N, Growdon JH. Biomarkers and surrogates. Neuro Rx 2004;1:181.